EBV T-Cell Treatment for MS: Trial Update MStranslate July 13, 2022 Epstein-Barr virus, Progressive MS, Research, Treatments Research Update: ATA188 Phase 2 EMBOLD Study Today, Atara Biotherapeutics provided an update on their Phase 2 randomised clinical trial, called the EMBOLD study, which is testing the safety and effectiveness...